Fundviser Capital (India) Limited (BOM:530197)
263.00
-8.00 (-2.95%)
At close: Feb 12, 2026
Fundviser Capital (India) Revenue
Fundviser Capital (India) had revenue of 513.35M INR in the quarter ending December 31, 2025, with 552.40% growth. This brings the company's revenue in the last twelve months to 1.39B, up 1,598.43% year-over-year. In the fiscal year ending March 31, 2025, Fundviser Capital (India) had annual revenue of 332.84M with 3,318.32% growth.
Revenue (ttm)
1.39B
Revenue Growth
+1,598.43%
P/S Ratio
1.12
Revenue / Employee
232.36M
Employees
6
Market Cap
1.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 332.84M | 323.11M | 3,318.32% |
| Mar 31, 2024 | 9.74M | 7.52M | 339.51% |
| Mar 31, 2023 | 2.22M | 500.40K | 29.18% |
| Mar 31, 2022 | 1.72M | -6.62M | -79.43% |
| Mar 31, 2021 | 8.34M | 5.44M | 187.77% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Modern Engineering and Projects | 1.15B |
| Trans India House Impex | 606.33M |
| Kabra Drugs | 269.14M |
| Maha Rashtra Apex Corporation | 81.31M |
| IB Infotech Enterprises | 79.99M |
| Pratik Panels | 52.98M |
| Transchem | 24.24M |
| ZR2 Bioenergy | 201.00K |